125 related articles for article (PubMed ID: 25448719)
1. Lethal drug combination: arsenic loaded multiple drug mesoporous silica for theranostic applications.
Muhammad F; Zhao J; Wang N; Guo M; Wang A; Chen L; Guo Y; Li Q; Zhu G
Colloids Surf B Biointerfaces; 2014 Nov; 123():506-14. PubMed ID: 25448719
[TBL] [Abstract][Full Text] [Related]
2. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
[TBL] [Abstract][Full Text] [Related]
3. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
4. Real-time monitoring of arsenic trioxide release and delivery by activatable T(1) imaging.
Zhao Z; Wang X; Zhang Z; Zhang H; Liu H; Zhu X; Li H; Chi X; Yin Z; Gao J
ACS Nano; 2015 Mar; 9(3):2749-59. PubMed ID: 25688714
[TBL] [Abstract][Full Text] [Related]
5. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
6. Ternary-Responsive Drug Delivery with Activatable Dual Mode Contrast-Enhanced in Vivo Imaging.
Ren S; Yang J; Ma L; Li X; Wu W; Liu C; He J; Miao L
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31947-31958. PubMed ID: 30179443
[TBL] [Abstract][Full Text] [Related]
7. One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma.
Li ZY; Liu Y; Wang XQ; Liu LH; Hu JJ; Luo GF; Chen WH; Rong L; Zhang XZ
ACS Appl Mater Interfaces; 2013 Aug; 5(16):7995-8001. PubMed ID: 23869943
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
9. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
10. Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells.
Zhang Q; Vakili MR; Li XF; Lavasanifar A; Le XC
Biomaterials; 2014 Aug; 35(25):7088-100. PubMed ID: 24840615
[TBL] [Abstract][Full Text] [Related]
11. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery.
Lee JE; Lee N; Kim H; Kim J; Choi SH; Kim JH; Kim T; Song IC; Park SP; Moon WK; Hyeon T
J Am Chem Soc; 2010 Jan; 132(2):552-7. PubMed ID: 20017538
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic and Stable Conjugation of Thiolated Mesoporous Silica Nanoparticles with Radioarsenic.
Ellison PA; Chen F; Goel S; Barnhart TE; Nickles RJ; DeJesus OT; Cai W
ACS Appl Mater Interfaces; 2017 Mar; 9(8):6772-6781. PubMed ID: 28165700
[TBL] [Abstract][Full Text] [Related]
13. Responsive delivery of drug cocktail via mesoporous silica nanolamps.
Muhammad F; Guo M; Wang A; Zhao J; Qi W; Guo Y; Zhu G
J Colloid Interface Sci; 2014 Nov; 434():1-8. PubMed ID: 25151090
[TBL] [Abstract][Full Text] [Related]
14. PEG-grafted arsenic trioxide-loaded mesoporous silica nanoparticles endowed with pH-triggered delivery for liver cancer therapy.
Jiang L; Wang X; Raza F; Zhong H; Su J; Yuan WE; Qiu M
Biomater Sci; 2023 Jul; 11(15):5301-5319. PubMed ID: 37357799
[TBL] [Abstract][Full Text] [Related]
15. Efficient intracellular delivery of camptothecin by silica/titania hollow nanoparticles.
Kim C; Kim S; Oh WK; Choi M; Jang J
Chemistry; 2012 Apr; 18(16):4902-8. PubMed ID: 22422377
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe
Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D
Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047
[No Abstract] [Full Text] [Related]
17. Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs.
Zhang L; Zhang Z; Mason RP; Sarkaria JN; Zhao D
Sci Rep; 2015 May; 5():9874. PubMed ID: 25962872
[TBL] [Abstract][Full Text] [Related]
18. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
Chan MH; Lin HM
Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
[TBL] [Abstract][Full Text] [Related]
19. Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.
Chen Y; Chen H; Zhang S; Chen F; Sun S; He Q; Ma M; Wang X; Wu H; Zhang L; Zhang L; Shi J
Biomaterials; 2012 Mar; 33(7):2388-98. PubMed ID: 22177841
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica nanoparticles carrying multiple antibiotics provide enhanced synergistic effect and improved biocompatibility.
Gounani Z; Asadollahi MA; Pedersen JN; Lyngsø J; Skov Pedersen J; Arpanaei A; Meyer RL
Colloids Surf B Biointerfaces; 2019 Mar; 175():498-508. PubMed ID: 30572158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
